98208918 - VOLITION

Information

• Trademark
• 98208918

• Source

• Serial Number

  98208918

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  October 04, 2023
  a year ago

• Transaction Date

  January 07, 2025
  29 days ago

• Status Date

  January 07, 2025
  29 days ago

• Location Date

  January 07, 2025
  29 days ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 117

  Employee Name

  INNES,ISABEL J

• Attorney Docket Number

  D6747-3440

  Attorney Name

  Amanda G. Hyland

  Law Office Assigned Location Code

  M80

• Owners

  • Belgian Volition SRL

Case File Statements

• GS0051: Pharmaceutical, chemical, biological, medical preparations for treating diseases caused by epigenetic and nucleosomal changes, namely, cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); biological tissue cultures for medical, therapeutic and veterinary purposes for use in the fields of epigenetics and nucleosomes; chemical and biological reagents for medical, therapeutic and veterinary purposes for use in the fields of epigenetics and nucleosomes; Diagnostic reagents, preparations and substances for medical use in the field of epigenetics and nucleosomes; diagnostic reagents for medical and veterinary use; Diagnostic reagents for medical use for in vitro diagnosis; Diagnostic preparations for medical purposes for detection, monitoring and diagnosis of cancer, sepsis, Covid-19, infection, dementia, Alzheimer's disease, thrombosis, vascular damage and inflammation, autoimmune diseases, and disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Pharmaceutical preparations for the treatment of conditions related to in vivo and ex vivo organ and tissue transplant; Medical diagnostic assays for stem cell differentiation status; blood for medical and veterinary purposes; blood plasma; cultures of microorganisms for medical and veterinary use; diagnostic biomarker reagents for medical and veterinary purposes; Transplants, namely, living human allograft tissue
• GS0011: Chemicals and biological preparations used in industry and science; chemical and biological reagents for use in industry and science; diagnostic reagents for scientific and research purposes; chemical and biological preparations and reagents for use in diagnostic and analytical tests, including in vitro diagnostic laboratory tests, for scientific purposes and not for medical or veterinary purposes; Reagents for scientific use in the field of life sciences; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); assays for testing stem cell differentiation status, other than for medical or veterinary use
• GS0441: Medical services and veterinary services; diagnostic medical testing and treatment of disorders, namely, cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, and disorders associated with neutrophil extracellular traps (NETs); medical analysis services relating to the treatment of persons and animals; health care; hospital services; Veterinary services, namely, advisory of medical, diagnostic or surgical services for animals; human tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical clinic services; medical screening; medical equipment rental; epigenetic testing for medical purposes, namely, for diagnosing disease, monitoring disease and treatment efficacy; medical analysis for the diagnosis and treatment of persons and animals; Medical and health care services in the field of DNA, genetics and genetic testing; genetic testing of animals for diagnostic or treatment purposes; genetic testing of animals for diagnostic or treatment purposes; DNA and RNA analysis services for medical purposes in the field of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnosis and prognosis in the field of diseases related to epigenetic and nucleosomal changes, namely cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); genetic testing for medical purposes; Blood analysis services for diagnostic purposes provided by medical laboratories; Veterinary analysis services for diagnostic and treatment purposes provided by veterinary laboratories
• GS0101: Surgical apparatus and instruments for medical and veterinary use; medical and therapeutic apparatus and instruments for use in treatment of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS) in humans and animals; Medical and veterinary devices for diagnosing cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs) pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for analyzing and measuring cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in the diagnosis, monitoring and treatment of cancer; medical apparatus, instruments and equipment for use in the monitoring and diagnosis of sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage and inflammation, disorders associated with neutrophil extracellular traps (NETs) and pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in monitoring the immune system, namely, for monitoring blood properties; Medical diagnostic apparatus for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for use with chemical and biological reagents, for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical apparatus for use in carrying out diagnostic assays; Medical apparatus, equipment and instruments for monitoring diseases namely, cancer sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); apparatus for DNA and RNA testing for medical purposes; Medical apparatus for use in regeneration of transplant tissues and organs; blood testing apparatus; dialyzers; apheresis devices for medical use; structural parts for all the aforesaid goods
• GS0421: Scientific and technological services, namely, custom design of chemical reagents and biological assays and research, all in the field of epigenetics and nucleosomes; Industrial research and scientific analysis in the field of epigenetics and nucleosomes; research and development services in the field of biotechnology, medical technology, assays, medical diagnostics, diagnostic reagents, substances, preparations and materials, detection of cancer and other diseases; scientific consulting in the field of research and development of biotechnology, medical technology, assays, medical diagnostic reagents, and technology for detecting cancer and other diseases; Providing analytical reagent sample testing and diagnostics services for others for scientific research purposes in the field of epigenetics and nucleosomes; Product design and development in the field of medical diagnostic testing apparatus and reagents; Blood analysis services for scientific research purposes; Veterinary research laboratory services; DNA and RNA analysis services for scientific research purposes in the field of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant health, thrombosis, vascular damage, inflammation, disorders associated with the immune system and disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS)

Case File Event Statements

• 10/7/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/13/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/25/2024 - 7 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/25/2024 - 7 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/23/2024 - 8 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/25/2024 - 7 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/11/2024 - 4 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/11/2024 - 4 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/11/2024 - 4 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/17/2024 - 3 months ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/18/2024 - 2 months ago

  11 - WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST Type: PBSR

• 1/7/2025 - 29 days ago

  14 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/7/2025 - 29 days ago

  15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/7/2025 - 29 days ago

  12 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/7/2025 - 29 days ago

  13 - NON-FINAL ACTION WRITTEN Type: CNRT